Archived copies of the webcasts will be available for up to one year on the āInvestorsā section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events.
Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Feb. 6, 2025 ā Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...
The Puma logo has been made more concise and more accessible over time. Its current form is smooth and contemporary, representing its namesake's swiftness and lightness. Maybe Reebokās vector logo ...
It is essential to understand the 7 different types of logos and when to use them. Each type has strong and weak points - Need professional help? Ever wonder why some logos stick in your mind like ...
Acute bronchitis, also known as a chest cold, is inflammation of the bronchi (the main tubes carrying air to your lungs). Your bronchi can swell and make mucus when they become inflamed. The common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results